Coverage Universe

Companies work with LifeSci Capital because of our distinct influence over investor engagement and behavior

Sort by Sector

Abivax
(ABVX.PA)

Analyst: Adam Evertts

Immunology and inflammation

Aeglea
(AGLE)

Analyst: Sam Slutsky

Rare disease

Allakos
(ALLK)

Analyst: Sam Slutsky

Immunology and inflammation

ALX Oncology
(ALXO)

Analyst: Adam Evertts

Oncology

Avadel
(AVDL)

Analyst: Adam Evertts

CNS

Bellus
(BLU)

Analyst: Sam Slutsky

Respiratory

BetaBionics
(Private)

Analyst: Rahul Rakhit

Medical technology

Better Therapeutics
(BTTX)

Analyst: Rahul Rakhit

Digital Health

Calliditas
(CALT)

Analyst: Rami Katkhuda

Nephrology

Catalyst Biosciences
(CBIO)

Analyst: Sam Slutsky

Immunology and inflammation

Celldex
(CLDX)

Analyst: Sam Slutsky

Immunology and inflammation

Cogent
(COGT)

Analyst: Sam Slutsky

Oncology

CymaBay
(CBAY)

Analyst: Patrick Dolezal

Rare disease

DarioHealth
(DRIO)

Analyst: Rahul Rakhit

Digital Health

Eledon
(ELDN)

Analyst: Rami Katkhuda

Immunology and inflammation

Immunovant
(IMVT)

Analyst: Sam Slutsky

Immunology and inflammation

InflaRx
(IFRX)

Analyst: Sam Slutsky

Immunology and inflammation

Inhibrx
(INBX)

Analyst: Adam Evertts

Rare disease

Larimar
(LRMR)

Analyst: Patrick Dolezal

Rare disease

Lucira Health
(LHDX)

Analyst: Rahul Rakhit

Diagnostics

MEI Pharma
(MEIP)

Analyst: Adam Evertts

Oncology

Nano-X Imaging
(NNOX)

Analyst: Rahul Rakhit

Medical technology

Olema
(OLMA)

Analyst: Adam Evertts

Oncology

Orchestra Biomed
(Private)

Analyst: Rahul Rakhit

Medical technology

Oyster Point
(OYST)

Analyst: Patrick Dolezal

Opthalmology

Pear Therapeutics
(PEAR)

Analyst: Rahul Rakhit

Digital Health

Pyxis Oncology
(PYXS)

Analyst: Adam Evertts

Oncology

Renovacor
(RCOR)

Analyst: Patrick Dolezal

Genetic medicines

Rocket Pharmaceuticals
(RCKT)

Analyst: Patrick Dolezal

Genetic medicines

Sierra Oncology
(SRRA)

Analyst: Sam Slutsky

Oncology

Tarsus
(TARS)

Analyst: Patrick Dolezal

Opthalmology

Tenaya Therapeutics
(TNYA)

Analyst: Patrick Dolezal

Genetic medicines

VectivBio
(VECT)

Analyst: Patrick Dolezal

Rare disease

Ventyx
(VTYX)

Analyst: Sam Slutsky

Immunology and inflammation

Vera Therapeutics
(VERA)

Analyst: Rami Katkhuda

Nephrology

Verve
(VERV)

Analyst: Patrick Dolezal

Genetic medicines

Vincerx
(VINC)

Analyst: Adam Evertts

Oncology

Viridian Therapeutics
(VRDN)

Analyst: Rami Katkhuda

Immunology and inflammation

VYNE Therapeutics
(VYNE)

Analyst: Patrick Dolezal

Rare disease

We are a full service investment bank specializing in the life sciences and healthcare